Interface Biologics, Inc.

Photos

Description

Ripple Therapeutics

The Ripple Therapeutics' Epidel technology is founded on a discovery that drugs can be engineered into controlled release Pharmaceuticals and Medical Device Coatings without the use of polymers or excipients. Our lead product (IBE-814 IVT) is a fully degradable intravitreal dexamethasone prodrug implant targeting DME, RVO and NIU indications.

Contacts

Phone
+14166738170

Address:
101 College St, Toronto, ON M5G 1L7

Website:
https://www.interfacebiologics.com/